Join us in creating a world where cancer is preventable, detectable and beatable for all.

Spenden Sie noch heute

Prevent Cancer Annual Gala on track for record-breaking fundraising numbers


ZUR SOFORTIGEN VERÖFFENTLICHUNG

Kyra Meister
703-836-1746
kyra.meister@preventcancer.org

Washington, D.C - On Sept. 15, the Prevent Cancer Foundation will open the doors of the National Building Museum for the Foundation’s 2022 gala. The group broke records last year, raising $2 million at its December 2021 gala. This year’s event is currently on track to surpass that fundraising total in support of cancer prevention and early detection.

Proceeds from the Gala will support Foundation programs, including research grants and fellowships and community grants. Funds will also support many of the Foundation’s public education campaigns, such as “Back on the Books,” which encourages everyone to schedule their routine cancer screenings, and “Too Young for This Sh*t,” which educates the public about the rise of colorectal cancer in young adults.

Each year, the Prevent Cancer Foundation Annual Gala honors a country that shares its commitment to ending cancer. The 2022 Gala will pay tribute to Australia, honoring His Excellency, Ambassador Arthur Sinodinos AO and Mrs. Elizabeth Sinodinos. This year’s event, themed Bounding Ahead, will feature an evening of live music and inspirational stories while highlighting some of Australia’s delicacies and delights.

The Foundation will present the 2022 Cancer Champion award to Senators Mike Crapo (R-Idaho) and Michael Bennet (D-Colo.) and Representatives Terri Sewell (D-Ala.), Jodey Arrington (R-Texas), Raul Ruiz (D-Calif.) and Richard Hudson (R-N.C.) for their leadership on the Medicare Multi-Cancer Early Detection Screening Coverage Act (S.1873 and H.R. 1946). With this bill, they aim to overcome access barriers that exist for Medicare beneficiaries by creating a pathway for timely coverage of multi-cancer early detection tests once they are approved by the Food and Drug Administration and clinical benefit is shown.

The Gala is recognized as one of Washington’s premier events and was ranked number four among all Washington charity events in 2018 and 2019 by Biz Bash. It is a widely attended event, with past guests including members of Congress and the administration; the diplomatic community; and leaders in business, government, medical, sports, media, social and philanthropic communities.

D.C. media is invited to attend and report on the Gala:

What: Prevent Cancer Annual Gala

When: Thursday, Sept. 15 at 6:00 p.m. ET

Where: National Building Museum, 401 F St. NW, Washington, D.C. 20001

Dress: Business or formal attire

If you plan to attend, please RSVP to kyra.meister@preventcancer.org by Monday, Sept. 12. Please note that members of the press will not be seated for dinner. Before you RSVP, please review our COVID-19 safety guidelines and vaccination requirements.

Registration for the Stille Auktion will open on Thursday, Sept. 1. Learn more about the Prevent Cancer Annual Gala.

The 2022 Prevent Cancer Gala thanks its top sponsors:

Presenting Sponsor: 

  • GRAIL

Diamond: 

  • Community Oncology Alliance 
  • Daiichi Sankyo 
  • Gilead 
  • Johnson & Johnson 
  • Pfizer 
  • PhRMA 
  • Shure Family Charitable Foundation

Platinum: 

  • Amgen 
  • Bristol Myers Squibb 
  • Regeneron

###

Über die Prevent Cancer Foundation®

Die Stiftung Prevent Cancer® ist die einzige gemeinnützige Organisation in den USA, die sich ausschließlich darauf konzentriert, Leben aller Bevölkerungsgruppen durch Krebsvorsorge und Früherkennung zu retten. Durch Forschung, Aufklärung, Öffentlichkeitsarbeit und Interessenvertretung haben wir unzähligen Menschen geholfen, eine Krebsdiagnose zu vermeiden oder ihren Krebs früh genug zu erkennen, um erfolgreich behandelt werden zu können.

Die Stiftung stellt sich der Herausforderung, die Zahl der Krebstoten bis 2035 um 401 TP3T zu senken. Um dieses Ziel zu erreichen, haben wir uns verpflichtet, 1 TP4T20 Millionen in innovative Technologien zur Krebsfrüherkennung und zur Verbesserung des Multi-Krebs-Screenings zu investieren, 1 TP4T10 Millionen in die Ausweitung des Zugangs zu Krebsscreenings und Impfungen auf medizinisch unterversorgte Gemeinden und 1 TP4T10 Millionen in die Aufklärung der Öffentlichkeit über Screening- und Impfmöglichkeiten.

Für weitere Informationen, besuchen Sie bitte www.preventcancer.org.